Background: Renal artery stenting is performed for renal artery injuries to preserve renal function and prevent renovascular hypertension. However, its indications are controversial and its long-term prognosis remains unknown. Here, we evaluate the characteristics and long-term outcomes of renal artery stenting for blunt renal artery injuries at our institution.
It was difficult to evaluate contusion and subcapsular hematoma in renal parenchyma for ischemic change.
servative therapy is chosen for a renal artery injury with stenosis/occlusion in a state of shock because the treatments of other injuries are given priority. For a hemodynamically stable renal artery injury with stenosis/occlusion, there are various choices of treatment. Conservative therapy or surgical revascularization is generally chosen as the treatment for these hemodynamically stable injuries 1,3 6 . However, the incidence of complications with conservative therapy, such as acute renal failure or renovascular hypertension is as high as 19%-43% 3, 7 . Furthermore, the success rate of surgical revascularization is poor, 25%-50% 3 7 .
For these reasons, renal artery injuries have been treated with renal artery stenting since the mid-1990s to preserve renal function and prevent renovascular hypertension 8 . However, its indications are controversial. The long-term prognosis remains unknown, and its evaluation as a treatment has not yet been determined 9 11 .
The aim of the present study was to evaluate the characteristics and long-term outcomes of renal artery stenting for blunt renal artery injuries at our institution.
Materials and Methods
This study involved a retrospective chart review at our institution. We examined medical records dated between Table 1 ). The remaining five were treated with renal artery stenting and were included in this study ( Renal artery injuries were detected with contrast CT and performed when the patients had stabilized (i.e., they had recovered from shock and did not require continuous rapid infusion or transfusion). Using a multidetector row CT scanner, we obtained images for two phases, the arterial dominant phase and the parenchymal phase, and made sure there was no active bleeding in either phase. A maximum intensity projection image of the abdominal aorta was then created using the arterial dominant phase and the appearance of the injury was evaluated in detail. With no protocol specifying the indication for renal artery stenting, the role of stenting for each patient was decided by discussion between the attending surgeon and the radiologists.
The types of stent used were "Palmaz" (Cordis Corporation, Warren, NJ, USA) for two patients, "Palmaz genesis" (Cordis Corporation, Warren, NJ, USA) for two patients, and "Express SD" (Boston Scientific Corporation, Natick, MA, USA) for one patient. Renal artery stenting for renovascular trauma is off-label use with these devices.
When the general condition of the patient allowed the initiation of anticoagulation therapy, we administered enteral antiplatelet agents, specifically aspirin, or a continuous intravenous infusion of heparin, as early as possible after stenting. Subsequently, patients were administered antiplatelet agents at least for 3 months.
Renal parenchymal injuries were graded according to the renal injury scale of the American Association for the Surgery of Trauma 12 . We defined acute renal failure as renal function disorder equivalent to "Failure" according to the RFILE classification 13 , and post-traumatic renovascular hypertension as acute onset secondary hypertension (systolic blood pressure ! 150 mmHg or diastolic blood pressure ! 90 mmHg) where the cause was not considered to be anything other than the renal artery injury 14 .
Patients 
Results
The characteristics of the patients with renal artery injuries treated with endovascular stenting are shown in Table 2. A total of five patients were included (three men and two women), of which two patients were aged less than 20 years and the others were aged 28, 37, and 62 years.
The cause of injury was falling from height in three patients and traffic accidents in the remaining two. All patients had experienced multiple injuries (median ISS, 24
[range, The outcomes of endovascular stenting for renovascular trauma are shown in Table 3 . The time between in- PRA and PAC levels also normalized within a month (PRA, 0.6 ng/mL/h; and PAC, 37 pg/mL).
Anticoagulation therapy was initiated for all five patients after stenting. We initiated the therapy for one patient (Case 4) on day 1 and for three patients (Case 1, 3, and 5) on day 3. The timing was unknown for Case 2.
Postoperative CT was performed on all patients, demonstrating no stent occlusion or renal atrophy. Renal scintigraphy was performed for three patients between 1 and 8 months after their injury. In all these cases, differential renal function was preserved at a level of >25%. All five patients survived.
Discussion
The results of our study suggest that stenting for renal artery injury with stenosis could preserve renal function and prevent renovascular hypertension even if significant time was taken for stenting after injury. A good longterm prognosis could be expected. Additionally, we were able to avoid complications associated with the procedure itself.
Indications for stenting in this study were hemodynamically stable blunt renal artery injuries with stenosis and no active bleeding from the renal parenchyma on contrast CT. With penetrating trauma, some arterial injuries with transection or avulsion have an appearance similar to stenosis/occlusion on contrast CT 15, 16 . We therefore consider stenting to be contraindicated for penetrating trauma. In hemodynamically unstable patients, diagnosis and treatment of the cause is the main concern. We suggest that stenting is contraindicated for patients with extravasation from the renal parenchyma or blood vessels on contrast CT because the stenting can promote bleeding. The presence of a hematoma in the para-renal space, outside Gerota's fascia, is also a contraindication because bleeding can be expected imminently 17 . Conversely, we would not necessarily consider a small hematoma in the peri-renal space, inside Gerota's fascia, to be a contraindication for this treatment 18 . However, renal parenchymal injuries with renal artery injuries are sometimes unclear on contrast CT because of malperfusion caused by vessel injuries. This malperfusion can mask parenchymal injuries. Consequently, promoting hemorrhage by recanalization with stenting should be a concern even in cases without either injury or active bleeding in the renal parenchyma on contrast CT 19 . In addition, general stenting should not be performed for contraindicated patients (e.g., those with severe blood vessel meandering, allergy, or selected anticoagulation therapies). Stenting for total renal artery occlusion had not been attempted at our institution because of complications, such as perioperative bleeding 19 .
Differences in the degree of stenosis did not significantly influence the outcomes of this study. In our opinion, total occlusion influences the outcome to a greater extent than stenosis. Irreversible changes in renal parenchyma occur when total occlusion of a renal artery continues for ! 1 h 20 22 . In a total renal artery occlusion, multi-ple thrombi in the distal renal arteries are likely to progress rapidly within 3 h, as was observed by Kushimoto et al. 23 Stenting at >3 h after an injury for the total occlusion could prevent renovascular hypertension but would not preserve adequate differential renal function in most cases 10, 19, 23, 24 . Renal blood flow is mainly dependent on the renal arteries, but there is also a collateral arterial supply (e.g., from the renal capsular arteries or adrenal arteries) 25, 26 . In a case of total occlusion, collateral supply does not keep sufficient renal blood flow; however, collateral supply may work in a case of stenosis. Indeed, our cases with severe 99% stenosis (Case 2 and 5) were able to preserve adequate differential renal function although Case is desirable to evaluate differential renal function with renal scintigraphy at least once. Regular ultrasonography is useful for follow-up 29 . In our study, renal scintigraphy was performed on three of five cases, and an adequate differential renal function was preserved in these three cases. Long-term follow-up after stenting revealed no renal atrophy in all the five cases. An endovascular stent with patency would be effective in preserving long-term renal function.
The largest study to date on stenting for blunt renal artery injuries included eight cases from three institutions in Texas, USA 19 . Intraoperative bleeding developed in two of these cases, and another two patients developed renovascular hypertension. The final renal function of the affected side was preserved in four of the eight cases.
Stenting was performed in seven total occlusion cases in their study. In contrast, we performed stenting only for stenosis cases. This potentially accounts for any differences observed between the two studies with respect to success and complication rates.
The present study has some limitations. It was a retrospective observational study including a small number of patients. Because we did not follow a specific protocol for indications and procedures for renal artery stenting, there were no uniformity patient indications and the procedures that they underwent. Moreover, there was no control group, so we cannot accurately determine the effectiveness and safety of renal artery stenting for blunt renal artery injuries.
We reviewed five hemodynamically stable patients with blunt renal artery injuries and stenosis, who were treated with stenting at our institution. All the patients survived and no complications due to the intervention itself were observed. Furthermore, all preserved renal function without irreversible renovascular hypertension.
Renal artery stenting for hemodynamically stable blunt renal artery injuries with stenosis is suggested to be safe and helps in avoiding long-term hemodialysis and renovascular hypertension. We therefore consider renal artery stenting to be a favorable treatment option for blunt renal artery injuries with stenosis.
